학술논문

The cost‐effectiveness of universal hepatitis B screening for reaching WHO diagnosis targets in Australia by 2030.
Document Type
Article
Source
Medical Journal of Australia; Mar2023, Vol. 218 Issue 4, p168-173, 6p
Subject
MEDICAL screening
HEPATITIS B
CHRONIC hepatitis B
HEPATITIS B virus
COST effectiveness
MARKOV processes
Language
ISSN
0025729X
Abstract
Copyright of Medical Journal of Australia is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)